Skip to content

Renal

Active Private limited companyfounded 2009active for 17 yearsKloosterstraat 68, 2990 WuustwezelKBO/BCE: BE 0809.647.320

Annual accounts 2025

micro format, filed on 10-08-2026, 10 days late
-€15,406
▼ €96,510
-€32,045
▼ €95,587
-€31,526
▼ €76,705
€235,805
▼ 6.5%
89.8%
▼ 3.7 percentage points
9.50
▼ 4.66

The abbreviated and micro formats do not require turnover, and these accounts state none. Without turnover there is no EBIT margin either.

Balance sheet

balance sheet total €270,807 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

89.8%

Higher than 89% of the 10,299 companies filing micro accounts in office administrative support (NACE 82) in 2025.

9.50

Higher than 90% of the 9,879 companies filing micro accounts in office administrative support (NACE 82) in 2025.

-11.6%

Higher than 11% of the 10,021 companies filing micro accounts in office administrative support (NACE 82) in 2025.

Renal Middle half of the sector 80% of the sector Micro accounts in office administrative support (NACE 82)

Net result: bottom quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020
-16,91579,47369,18478,61198,88796,877
-16,39661,11052,66058,80871,71871,823
017,0001,29529,4708,711-
-111,57071,89350,696-3,61330,306-
235,805252,201208,091156,725126,49563,488
89.8%93.5%99.7%97.1%69.9%69.4%
9.5014.16-28.843.153.08
0.110.070.000.030.430.44
-13.0%16.5%17.4%27.9%49.3%101.5%
-11.6%15.4%17.4%27.1%34.4%70.4%
-94.56over 100over 100over 100over 100-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020
Balance sheet: assets
20/58 270,807293,751230,174195,037195,45499,779
21/28 7,25522,38521,31732,68210,0705,748
22/27 6,77521,90520,83732,2029,5905,748
23 3327792,0721,9162,054-
24 6,44321,12618,76430,2867,5365,748
28 480480480480480-
29/58 263,551271,365208,857162,355185,38494,031
40/41 153,08150,08159,57963,00280,61720,696
40 72014,93622,94022,19015,73119,138
41 152,36135,14436,64040,81264,8861,558
54/58 107,365218,935147,04296,34699,95969,653
490/1 3,1052,3502,2363,0074,8083,682
Balance sheet: equity and liabilities
10/49 270,807293,751230,174195,037195,45499,779
10/15 243,060274,586229,407189,407136,56569,235
10/11 1,0001,0001,0001,0001,0001,000
13 273,586273,586228,407188,407135,56568,235
133 273,586273,586228,407188,407135,56568,235
14 -31,526-----
17/49 27,74619,1647665,63058,88930,544
42/48 27,74619,1647665,63058,88930,544
44 -1,6527662,8501,6001,150
440/4 -1,6527662,8501,6001,150
45 13,59714,265-36452,64625,291
450/3 13,59714,265-36452,64625,291
47/48 14,1493,247-2,4164,6424,102
Income statement
76A ---2,108--
9900 -15,40681,10572,86080,107100,94198,369
630 15,13015,93112,6605,9664,3891,545
640/8 1,5091,6323,6761,4962,0541,492
9901 -32,04563,54256,52472,64594,49895,332
75/76B 1,05354855576668271
75 1,05354855576668271
65/66B 179280237205180149
65 179280237205180149
9903 -31,17163,80956,84273,20695,00095,254
67/77 35518,63016,84120,36427,67024,976
9904 -31,52645,17940,00052,84267,32970,278
9905 -31,52645,17940,00052,84267,32970,278
Appropriation of the result
9906 -31,52645,17940,00052,84267,32968,235
691/2 -45,17940,00052,84267,32968,235
6921 -45,17940,00052,84267,32968,235
Document PDFPDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 10-08-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 10-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00390175.

Financial year Type Filed Reference Document
31-12-2025 micro format 10-08-2026 2026-00390175 PDF
31-12-2024 abbreviated format 04-07-2025 2025-00230106 PDF
31-12-2023 abbreviated format 20-07-2024 2024-00266238 PDF
31-12-2022 abbreviated format 08-07-2023 2023-00217446 PDF
31-12-2021 abbreviated format 20-06-2022 2022-20072632 PDF
31-12-2020 abbreviated format 21-06-2021 2021-21800376 PDF

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets-€17,000€1,295€29,470€8,231
Financial fixed assets----€480
€15,130€15,931€12,660€5,966€4,389

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on Renal

The operating result for 2025 is a loss of €32,045, after a profit of €63,542 in 2024. It is the lowest result since 2020.

Debt's share of the balance-sheet total rises from 6.5% to 10.2%. Equity is lower and debt is higher.

Next steps